<PAGE> 1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
[X] FORM 10-K [ ] FORM 20-F [ ] FORM 11-K [ ] FORM 10-Q [ ] FORM N-SAR
For Period Ended: December 31, 1998
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
- -------------------------------------------------------------------------------
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
- -------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates: ......................
...............................................................................
...............................................................................
- -------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
- -------------------------------------------------------------------------------
Full Name of Registrant: Rx Medical Services Corp.
Former Name if Applicable: ARM Financial Corp.
Address of Principal Executive Office (Street and Number)
888 East Las Olas Boulevard, Suite 210
City, State and Zip Code:
Fort Lauderdale, Florida 33301
<PAGE> 2
- -------------------------------------------------------------------------------
PART II - RULES 12B-25(b) AND (c)
- -------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25 (b), the following
should be completed. (Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without reasonable effort or expense;
[ ] (b) The subject annual report semi-annual report, transition report on Form
10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
- -------------------------------------------------------------------------------
PART III - NARRATIVE
- -------------------------------------------------------------------------------
State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof could not be filed within the
prescribed period.
Registrant does not anticipate that it will be able to file the Form
10-K for the year ended December 31, 1998 on or before the due date or
the extended due date pursuant to Rule 12b-25 for the following
reason:
Certain information necessary for the accurate completion of
the Form 10-K for the year ended December 31, 1998, is not
available at the present time.
Registrant anticipates that its Form 10-K for the year ended December
31, 1998 will be filed on or about July 31, 1999.
2
<PAGE> 3
- -------------------------------------------------------------------------------
PART IV - OTHER INFORMATION
- -------------------------------------------------------------------------------
(1) Name and telephone number of person to contact in regard to this
notification
Dennis A. Dolnick (954) 462-1711 [Ext. 14]
- -------------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d)
of the Securities Exchange Act of 1934 or section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report (s) been filed? If the answer is no,
identify report (s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
RX MEDICAL SERVICES CORP.
-------------------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 31, 1999 By: /s/ Randolph H. Speer
-------------------------------
Randolph H. Speer
President
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
- ----------------------------------------------------------------------
ATTENTION
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).
3
